Amgen Inc (AMGN)
294.52
+4.62
(+1.59%)
USD |
NASDAQ |
Nov 22, 16:00
294.53
+0.01
(+0.00%)
After-Hours: 20:00
Amgen Cash from Investing (Quarterly): -210.00M for Sept. 30, 2024
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | -210.00M |
| June 30, 2024 | -217.00M |
| March 31, 2024 | -217.00M |
| December 31, 2023 | -27.09B |
| September 30, 2023 | -262.00M |
| June 30, 2023 | -211.00M |
| March 31, 2023 | 1.358B |
| December 31, 2022 | -3.473B |
| September 30, 2022 | -267.00M |
| June 30, 2022 | -2.193B |
| March 31, 2022 | -111.00M |
| December 31, 2021 | -230.00M |
| September 30, 2021 | 73.00M |
| June 30, 2021 | 1.209B |
| March 31, 2021 | -319.00M |
| December 31, 2020 | -1.384B |
| September 30, 2020 | -1.628B |
| June 30, 2020 | -2.159B |
| March 31, 2020 | -230.00M |
| December 31, 2019 | -5.963B |
| September 30, 2019 | 5.372B |
| June 30, 2019 | 2.745B |
| March 31, 2019 | 3.555B |
| December 31, 2018 | -4.637B |
| September 30, 2018 | 1.132B |
| Date | Value |
|---|---|
| June 30, 2018 | 2.938B |
| March 31, 2018 | 14.91B |
| December 31, 2017 | -78.00M |
| September 30, 2017 | -1.976B |
| June 30, 2017 | -1.813B |
| March 31, 2017 | -157.00M |
| December 31, 2016 | -1.222B |
| September 30, 2016 | -2.389B |
| June 30, 2016 | -657.00M |
| March 31, 2016 | -4.39B |
| December 31, 2015 | -233.00M |
| September 30, 2015 | -2.003B |
| June 30, 2015 | -2.359B |
| March 31, 2015 | -952.00M |
| December 31, 2014 | 374.00M |
| September 30, 2014 | -2.903B |
| June 30, 2014 | -2.458B |
| March 31, 2014 | -765.00M |
| December 31, 2013 | -10.12B |
| September 30, 2013 | -2.119B |
| June 30, 2013 | 1.959B |
| March 31, 2013 | 1.809B |
| December 31, 2012 | -2.031B |
| September 30, 2012 | -3.173B |
| June 30, 2012 | -2.44B |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-27.09B
Minimum
Dec 2023
1.358B
Maximum
Mar 2023
-2.176B
Average
-246.00M
Median
Cash from Investing (Quarterly) Benchmarks
| Johnson & Johnson | -3.128B |
| Eli Lilly and Co | -4.005B |
| Merck & Co Inc | -3.845B |
| Regeneron Pharmaceuticals Inc | -574.40M |
| Viking Therapeutics Inc | 25.90M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 3.571B |
| Cash from Financing (Quarterly) | -3.651B |
| Free Cash Flow | 6.283B |
| Free Cash Flow Per Share (Quarterly) | 6.114 |
| Free Cash Flow to Equity (Quarterly) | 5.561B |
| Free Cash Flow to Firm (Quarterly) | 4.022B |
| Free Cash Flow Yield | 3.96% |